Insider insights on pharma career strategy, the DACH job market, LinkedIn, ATS systems, and executive recruitment. The knowledge that comes from 17 years on the other side of the desk — written for the candidates who deserve to know it.
Outplacement explained: who pays, who gets it, what happens phase by phase, how German, Austrian and Swiss rules touch it, and how to tell a good provider from a bad one.
Read more →What § 70 StrlSchG puts on the Strahlenschutzbeauftragter, which Fachkunde the law demands, how often it has to be refreshed, and who appoints one in pharma and medtech.
Read more →Who has to appoint a Gefahrgutbeauftragter, which exemptions apply, what the IHK Schulungsnachweis covers, and which UN numbers a pharma or medtech site actually ships.
Read more →What Article 97 of Regulation (EU) 2019/6 demands of the veterinary qualified person, how it differs from § 14 AMG, and where the German jobs sit under the TAMG.
Read more →What Articles 4 and 5 of Regulation (EC) 1223/2009 put on the responsible person, why the Article 10(2) diploma belongs to the safety assessor, and how Germany enforces it.
Read more →Pharmaingenieur is a job title, not a statutory appointment. What the work covers on a German site, which GMP rules bind it, and where it sits next to the named persons.
Read more →Medizintechnik-Ingenieur is a job title, not a statutory appointment. What the MDR binds on the manufacturer side, what the 2025 MPBetreibV binds in hospitals, and who hires.
Read more →Legal basis, who must appoint, and what each qualification test demands, with a career guide behind every role.
Read more →What the role owns behind the German wholesale licence, why the 2020 court ruling widened who qualifies, and the route in.
Read more →The Article 15 duties, the two qualification routes, and what replaced the German Sicherheitsbeauftragter.
Read more →The qualification routes, the reporting duty, and why clinical staff get hired into medtech field teams.
Read more →What the § 3 BtMG licence demands of the named person, which expertise routes § 6 BtMG accepts, and who is hiring.
Read more →The three qualification routes, why the Pharmareferent certificate is only one of them, and the duties in § 76.
Read more →What each function owns, why the two must stay independent, and how they relate to the Qualified Person.
Read more →The qualification written into the provision, what the seat answers for, and the realistic routes in.
Read more →Who has to appoint one, what the role owns, and why it works as a bridge from the clinic into medtech.
Read more →What the role under § 63a AMG actually does, the qualifications German authorities expect, and how it leads to the EU QPPV.
Read more →What Germany's mandatory information officer owns, the qualifications that count, and the career route into the appointment.
Read more →The § 15 AMG requirements, the realistic route through QC and QA to batch certification, and what the DACH market demands.
Read more →The qualifications, the realistic entry routes, and what recruiters and the ATS actually check for CRA roles.
Read more →What drives each promotion from RA Officer to Head of Regulatory Affairs, and how to position for the next rung.
Read more →The entry routes into drug safety that actually work, and what a pharmacovigilance CV must show.
Read more →How to reframe your GMP experience for a move into QA, and what a QA CV must evidence.
Read more →An insider recruiter compares the two most popular pharma career paths and how to choose.
Read more →Why Market Access and HEOR careers command a premium, and how the AMNOG process shapes the field.
Read more →Germany cannot fill its vacancies yet screens out the over-fifties. Age discrimination in DACH pharma hiring in 2026 — the data, the euphemisms, and five moves that actually work.
Read article →The '80% hidden job market' stat traces to a 1966 pamphlet. The real DACH numbers, the weak-ties science, and which networking actually works.
Read article →The most-reported LinkedIn job scam of 2026 is the fake recruiter who says your CV needs a paid rewrite. How it works, the one character that unmasks it, and how to stay safe.
Read article →54,000 German executives are unemployed — the highest since 2015. The DACH executive job market in 2026, the euphemisms, and five moves that actually work at any level.
Read article →AI auto-apply tools promise to job-hunt while you sleep. The data says they quietly torpedo your candidacy — and the EU AI Act regulates their robot, not yours.
Read article →22,000 Western pharma redundancies and a 62% Indian hiring surge are not separate phenomena — they are the same transaction. What it means for DACH pharma careers in 2026.
Read article →The '85% via networking' claim has no traceable source. The real number is 30–50% from referrals, and the actionable advice is more useful than the slogan.
Read article →Fourteen years watching pharma's technology waves. What AI will and won't take from medical writing, pharmacovigilance, biostatistics, and regulatory affairs in 2026.
Read article →Randstad Workmonitor 2026: 60% of German employees now rank job security above work-life balance. The data, the diagnosis, the strategy.
Read article →63.5% of applicants get no reply at all. The Indeed/Appinio survey, the EU Pay Transparency Directive (7 June 2026), and why pay transparency is the single biggest fix for ghosting in DACH pharma hiring.
Read article →Roughly 50–70% of senior DACH pharma roles are filled before they hit a job board. How to be the candidate recruiters source — not the one who applies in vain.
Read article →Germany's Opportunity Card is reshaping DACH pharma hiring competition. What it does, who is using it, and what it means for your salary and your next role.
Read article →Most pharma professionals treat LinkedIn as a CV. Recruiters read it as an argument. Here is how to write a profile that closes the case before paragraph two.
Read article →The honest answer from someone who screens CVs daily. What actually matters, what doesn't, and why the degree debate is more nuanced than LinkedIn thinks.
Read article →75% of CVs never reach a human recruiter — or do they? We separate ATS myth from reality, cover what DACH hiring actually looks like, and explain what changes from August 2026 under the EU AI Act.
Read article →93% of recruiters plan to increase AI use in 2026. Only 8% of candidates think AI makes hiring fair. What this really means for your pharma job search — and what the EU AI Act does about it.
Read article →Germany's four-day workweek trial results are in. What the data actually says about productivity, pharma hiring, and the future of work in DACH.
Read article →The EU Pay Transparency Directive is coming. How it reshapes pharmaceutical hiring in Germany, Austria, and Switzerland — and how to use it before everyone else does.
Read article →2027 is the year the patent cliff actually arrives, AI actually works, and your career either transforms or becomes obsolete. Here's the honest outlook.
Read article →180,000 new pharma jobs will be created in 2026 — and 95,000 will be destroyed. Here's how to be on the right side of that equation.
Read article →The patent cliff, AI disruption, and an outdated CV — three forces converging in 2026. What pharma professionals need to do now.
Read article →Pharma has an SOP for everything — except basic human decency in hiring. Five measures that could fix recruitment ghosting.
Read article →Let's play a game called "Spot the Fiction" — the uncomfortable truth about why your applications disappear into the void.
Read article →Job postings down 19%. Applications up 65%. Here's how to survive the most competitive pharma job market in a decade.
Read article →The pharma AI skills gap is 60%. For every 10 AI-competent candidates needed, only 4 exist. Here is what actually works to close that gap — and what is just expensive Quatsch.
Read article →42,700 pharmaceutical jobs eliminated in 2025 — 47% worse than 2024. What's really happening and what will actually save your career.
Read article →The viral LinkedIn post shaming a recruiter might feel good — but it's quietly destroying your chances. Here's what actually happens behind the scenes.
Read article →A thought experiment that reveals uncomfortable truths about modern hiring — and what you can do about it.
Read article →A former Big-Pharma recruiter debunks the five biggest ATS myths — the automatic 75% rejection, keyword mirroring, white-text hacks — and what actually moves your application.
Read article →The algorithms that pharmaceutical companies use to filter CVs are not as random as they feel. Here is exactly how they work — and how to beat them.
Read article →LinkedIn removed 80.6 million fake accounts in six months. Job scams surged 1,000%. The red flags real recruiters spot — and the ones candidates miss.
Read article →After 17 years in pharmaceutical recruitment, some clients transformed their trajectories. Others burned through savings on glorified CV formatting services. Here's how to tell the difference.
Read article →Toyota became the world's largest car manufacturer through disciplined continuous improvement. The same principle applies to your pharma career — here's how.
Read article →220 million professionals now use LinkedIn's green "Open to Work" banner — a 35% surge. Is it helping or hurting your pharma job search?
Read article →After 17 years in pharmaceutical talent acquisition, watching exceptional candidates with decades of expertise get passed over — the age bias conversation pharma needs to have.
Read article →Stop sending your 847th application to a Senior Pharma role you're "technically qualified" for. Here's what actually gets you hired.
Read article →Yes, I said it. The badge that's supposed to help you get hired might be doing the opposite. Here's why — and what to do instead.
Read article →Learn in five minutes how LinkedIn connections and direct messages can become one of your best job-hunting tools in pharma.
Read article →It's not their experience. It's not their skills. After 17 years in pharma recruitment, I've seen exceptional candidates become invisible — because of acronyms.
Read article →If an employer you admire is hiring but has nothing that fits, pick up the phone. Why a two-minute call beats another cold application — from a recruiter who remembers the callers.
Read article →A journalist let AI bots apply to jobs on her behalf. The results: £200 spent, wrong languages claimed, cover letters sent to the wrong companies. As a recruiter, I can assure you: we notice.
Read article →After 17 years in pharma recruitment: degrees open doors — but skills decide what happens once you're inside. Here's the cheat sheet.
Read article →A recruiter's take on cybersecurity: after 17 years in talent acquisition, here's why WhatsApp's latest breach matters for your career and data.
Read article →AI, drug discovery, and the billion-euro question: should pharmaceutical companies build their own supercomputers or rent someone else's?
Read article →Europe's 80% dependency on Asian pharmaceutical ingredients is a ticking time bomb. What it means for the industry and your career.
Read article →